Renewable Energy Group, Inc. (NASDAQ: REGI)
52-week Gain: 168.04%
Renewable Energy Group develops, sells, and distributes biofuels and renewable energy chemicals for companies throughout the U.S. The company recently announced a new research partnership with Exxon Mobil (NYSE:XOM) in an effort to expand Renewable Energy Group’s Life Sciences bio-conversion technology programs (which convert sugars from cellulosic biomass into biodiesel). Renewable Energy Group has a market cap of just over $1 billion, and these recent announcements should help the company continue to establish itself within the industry.
The stock is up by a massive 168.04% over the last 52-weeks, and these bullish trends have been supported by consistent quarterly earnings performances. Renewable Energy Group has beaten analyst estimates for EPS in three of the last four quarters, and the company has consistently grown earnings over the last four years (producing $2.2 billion in revenue in 2018). Despite this strong run higher, REGI is still trading with a PE ratio (TTM) of 4.51, which is firmly below its competitor averages which are present in the same industry group.
QuinStreet, Inc. (NASDAQ: QNST)
52-week Gain: 111.36%
QuinStreet is a performance-based internet marketing company which offers customer acquisition services both in the U.S. and around the world. The company provides online marketing services through qualified leads and display advertisements through third-party publishers and its own network of websites. QuinStreet provides its services in various verticals (i.e. business-to-business technology, financial services, home services, and education) and is headquartered in Foster City, California.
QuinStreet has steadily grown in revenue figures over the last four years, with significant increases visible in 2018. For the fourth quarter, the company is expected to show earnings of $0.12 per share (which is an annualized gain of 71.4%). Revenues for the period are expected to post at $104.27 million (an annualized gain of 19.2%).
eHealth, Inc. (NASDAQ: EHTH)
52-week Gain: 250.80%
eHealth, Inc. provides private health insurance services to families, small businesses, and individuals in the United States and China. The company’s online platforms operate in two segments: Individual/Family/Small Business and Medicare. eHealth’s e-commerce exchanges organize health insurance information in several formats which allow clients to research, analyze, compare, and purchase a broad range of health insurance program plans.
For the fourth quarter, the company expects net income levels to fall between $24.3 million and $27.3 million with revenues of $133.5 million to $135.5 million. Adjusted EBITDA is expected to post within a range of $51.7 million to $52.7 million. Analyst estimates for earnings imply a per-share figure of $1.83 on revenues of $111.5 million for the period. This indicates growth rates of 187% on the top line and 297% on the bottom line for eHealth (on an annualized basis).
Amedisys, Inc. (NASDAQ: AMED)
52-week Gain: 147.30%
Amedisys is a U.S. company which provides healthcare services that operate across three segments: Hospice, Personal Care, and Home Health. The company’s Home Health segment provides a wide range of services for patients recovering from surgery, suffering from chronic disabilities, or that have been diagnosed with a terminal illness. Amedisys aims to provide services which help prevent avoidable hospital readmissions (i.e. occupational therapists, physical and speech therapists, and nurses to aid with personal tasks).
Amedisys has displayed very stable revenue growth rates over the last four years and the company has beaten analyst estimates for earnings in three of the last four quarters. The stock has posted 52-week gains of 133.18% despite a deep pullback in sympathy with the broader equities market toward the end of 2018.
Disclaimer: The author and Spotlight Growth has no positions in any of the stocks mentioned in this article. Nor does either party currently have any relationship, or any other conflicts of interest, with any of the companies mentioned in this article. This content is meant for informational and entertainment purposes only and should not be meant as a recommendation to buy or sell any securities. Please visit a licensed financial representative to determine what investments are right for you.
Article By: Richard Cox
